Cargando…

High-dose bevacizumab for radiation-induced brain necrosis: a case report

Radiation-induced brain necrosis (RIBN) is a common adverse event from radiation therapy. We present a case of a 56-year-old man, diagnosed with non-small-cell lung cancer with brain metastases 2 years prior, for which he had received whole brain radiotherapy and brain stereotactic radiosurgery, who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panagiotou, Emmanouil, Charpidou, Andriani, Fyta, Eleni, Nikolaidou, Vasiliki, Stournara, Lamprini, Syrigos, Alexandros, Gkiozos, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410693/ https://www.ncbi.nlm.nih.gov/pubmed/37140173 http://dx.doi.org/10.2217/cns-2023-0002

Ejemplares similares

PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost–effectiveness
por: Gkogkozotou, Vasiliki-Konstantina I, et al.
Publicado: (2018)

CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022)

Serum and Pleural Soluble Cell Adhesion Molecules in Mesothelioma Patients: A Retrospective Cohort Study
por: Tsagkouli, Sofia, et al.
Publicado: (2022)

Malignant Superior Vena Cava Syndrome: State of the Art
por: Patriarcheas, Vasileios, et al.
Publicado: (2022)

310 Diagnosis and Management of Post-radiation Pneumonitis in Patients with Asthma
por: Syrigou, Ekaterini, et al.
Publicado: (2012)

Endobronchial ultrasound transbronchial needle aspiration in the evaluation of the mediastinum lymph nodes: safety evaluation
por: Syrigos, Kostantinos, et al.
Publicado: (2015)

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis
por: Alessandretti, Matheus, et al.
Publicado: (2013)

Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection
por: Syrigos, Kostantinos, et al.
Publicado: (2015)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020)

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review
por: Liao, Guixiang, et al.
Publicado: (2021)

Wedge Resection and Segmentectomy in Patients with Stage I Non-Small Cell Lung Carcinoma
por: Reveliotis, Konstantinos, et al.
Publicado: (2014)

Erlotinib-Associated Rash in Advanced Non-Small Cell Lung Cancer: Relation to Clinicopathological Characteristics, Treatment Response, and Survival
por: Kainis, Ilias, et al.
Publicado: (2018)

Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Clinical and Surgical-Pathological Staging in Early Non-Small Cell Lung Cancer
por: Koukis, Ioannis, et al.
Publicado: (2013)

Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series
por: Tijtgat, Jens, et al.
Publicado: (2023)

Modern radiopharmaceuticals for lung cancer imaging with positron emission tomography/computed tomography scan: A systematic review
por: Theodoropoulos, Athanasios S, et al.
Publicado: (2020)

Sampling Versus Systematic Full Lymphatic Dissection in Surgical Treatment of Non-Small Cell Lung Cancer
por: Koulaxouzidis, Georgios, et al.
Publicado: (2013)

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases
por: Trontzas, Ioannis P., et al.
Publicado: (2023)

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase‐positive lung cancer
por: Tanigawa, Kengo, et al.
Publicado: (2019)

Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
por: Hong, Christopher, et al.
Publicado: (2019)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
por: Syrigos, Nikolaos, et al.
Publicado: (2022)

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases
por: Weng, Yuxiang, et al.
Publicado: (2021)

BEVACIZUMAB FOR SYMPTOMATIC RADIATION NECROSIS IN BRAIN METASTASES: OUTCOMES FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS
por: Roberto, Katrina, et al.
Publicado: (2023)

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
por: Wang, Yang, et al.
Publicado: (2012)

Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis
por: Li, Honghong, et al.
Publicado: (2021)

Neutrophil to lymphocyte ratio as a predictor for treatment of radiation‐induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients
por: Cai, Jinhua, et al.
Publicado: (2022)

Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature
por: Delishaj, Durim, et al.
Publicado: (2017)

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab
por: Voss, Martin, et al.
Publicado: (2019)

Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical Results
por: Anagnostopoulos, Athanasios K., et al.
Publicado: (2022)

A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis(†)
por: Furuse, Motomasa, et al.
Publicado: (2016)

Single-shot bevacizumab for cerebral radiation injury
por: Voss, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rh86f8evp7m3k406lnl7ijmlc9